Literature DB >> 12515459

Novel stereoselective synthesis of functionalized oxazolidinones from chiral aziridines.

Chan Sun Park1, Min Sung Kim, Tae Bo Sim, Do Kyu Pyun, Cheol Hae Lee, Daeock Choi, Won Koo Lee, Jae-Won Chang, Hyun-Joon Ha.   

Abstract

Enantiomerically pure N-(R)-alpha-methylbenzyl-4(R)-(chloromethyl)oxazolidinones (4R)-5a-k were synthesized in one step and high yields from various aziridine-2-methanols (S)-2a-k by intramolecular cyclization with phosgene. The alpha-methylbenzyl substituent on the nitrogen was easily cleaved to give both enanatiomers of 4-(chloromethyl)oxazolidinones (R)-7a and (S)-7a. (R)-7a was used for the efficient syntheses of (L)-homophenylalaninol analogues (S)-12a-j. We also applied the same methodology to prepare oxazolidinones 9a-c containing a heteroatom-substituted alkyl group at C-4 in high yields.

Entities:  

Year:  2003        PMID: 12515459     DOI: 10.1021/jo025545l

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Catalytic, Enantioselective Synthesis of Cyclic Carbamates from Dialkyl Amines by CO2-Capture: Discovery, Development, and Mechanism.

Authors:  Roozbeh Yousefi; Thomas J Struble; Jenna L Payne; Mahesh Vishe; Nathan D Schley; Jeffrey N Johnston
Journal:  J Am Chem Soc       Date:  2018-12-24       Impact factor: 15.419

Review 2.  N-(1-Phenylethyl)aziridine-2-carboxylate esters in the synthesis of biologically relevant compounds.

Authors:  Iwona E Głowacka; Aleksandra Trocha; Andrzej E Wróblewski; Dorota G Piotrowska
Journal:  Beilstein J Org Chem       Date:  2019-07-23       Impact factor: 2.883

3.  Synthesis of chiral 1,4-disubstituted-1,2,3-triazole derivatives from amino acids.

Authors:  Michael Klein; Karin Krainz; Itedale Namro Redwan; Peter Dinér; Morten Grøtli
Journal:  Molecules       Date:  2009-12-09       Impact factor: 4.411

Review 4.  Synthetic Applications of Aziridinium Ions.

Authors:  Jala Ranjith; Hyun-Joon Ha
Journal:  Molecules       Date:  2021-03-22       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.